{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:14Z","timestamp":1787238014494,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Sepsis remains a disease with a high mortality rate. The study goal was to assess long-term survival of severe sepsis in young patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Patients admitted with sepsis to ICUs in seven tertiary hospitals between 2003 and 2011.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>A total of 409 patients less than 45 years who survived to hospital discharge were age and sex matched with 818 patients with infectious disease without sepsis selected from internal medicine or surgical department admissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      The median age in sepsis patients and the comparison group was 31 and 32 years, respectively. The proportions of patients surviving after hospital discharge were significantly lower in the sepsis group compared with the control group; among survivors, 6-month, 1-year, and 3-year mortality rates were 0.7% versus 0%, 4.5% versus 0.7%, 7.9% versus 1.2%, and 10.8% versus 1.8%, respectively (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001 for all). In a multivariate Cox proportional hazards regression model, sepsis was associated with an increased risk of mortality (hazard ratio, 3.79; 95% CI, 2.27\u20136.32), while controlling for age, Charlson Comorbidity Index, history of stroke, and congestive heart failure. Past the 24-month landmark, sepsis was not found to be an independent risk for mortality (hazard ratio, 1.79; 95% CI, 0.67\u20134.79). Based on cause of death analysis, chronic underlying comorbidities might explain the excess mortality in patients with sepsis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Young patients experiencing an episode of severe sepsis continue to be at higher risk of long-term mortality. The highest mortality rates were observed during the first 24 months following discharge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000003205","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T21:39:30Z","timestamp":1525815570000},"page":"1269-1275","source":"Crossref","is-referenced-by-count":19,"title":["Long-Term Survival of Young Patients Surviving ICU Admission With Severe Sepsis*"],"prefix":"10.1097","volume":"46","author":[{"given":"Heba","family":"Abu-Kaf","sequence":"first","affiliation":[{"name":"Department of Internal Medicine \"D\", Division of Internal Medicine, Soroka University Medical Center, Beer Sheva, Israel."},{"name":"Clinical Research Center, University Soroka Medical Center, Beer Sheva, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Mizrakli","sequence":"additional","affiliation":[{"name":"Clinical Research Center, University Soroka Medical Center, Beer Sheva, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Novack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Dreiher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine.","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis.","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock.","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients.","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/cc6195","article-title":"A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: Comparison of recombinant human activated protein C with standard care.","volume":"11","author":"Longo","year":"2007","journal-title":"Crit Care"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000.","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jama.1997.03550030074038","article-title":"Epidemiology of sepsis syndrome in 8 academic medical centers.","volume":"278","author":"Sands","year":"1997","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R10-20230816","first-page":"S64","article-title":"The epidemiology of the systemic inflammatory response.","volume":"26","author":"Brun-Buisson","year":"2000","journal-title":"Intensive Care Med"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1097\/01.CCM.0000186748.64438.7B","article-title":"Facing the challenge: Decreasing case fatality rates in severe sepsis despite increasing hospitalizations.","volume":"33","author":"Dombrovskiy","year":"2005","journal-title":"Crit Care Med"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.mayocp.2014.07.009","article-title":"Severe sepsis and septic shock: Clinical overview and update on management.","volume":"89","author":"Cawcutt","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"R13-20230816","first-page":"521","article-title":"Severe sepsis in managed care: Analysis of incidence, one-year mortality, and associated costs of care.","volume":"10","author":"Braun","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/cc2818","article-title":"Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness.","volume":"8","author":"Granja","year":"2004","journal-title":"Crit Care"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1097\/00003246-200011000-00006","article-title":"Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life.","volume":"28","author":"Heyland","year":"2000","journal-title":"Crit Care Med"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1213\/ane.0b013e318187bbd8","article-title":"The impact of severe sepsis on health-related quality of life: A long-term follow-up study.","volume":"107","author":"Hofhuis","year":"2008","journal-title":"Anesth Analg"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.1995.03530040066043","article-title":"Long-term survival and function after suspected gram-negative sepsis.","volume":"274","author":"Perl","year":"1995","journal-title":"JAMA"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis.","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.CCM.0000085178.80226.0B","article-title":"Long-term mortality and medical care charges in patients with severe sepsis.","volume":"31","author":"Weycker","year":"2003","journal-title":"Crit Care Med"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jama.1997.03540370048035","article-title":"Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group.","volume":"277","author":"Quartin","year":"1997","journal-title":"JAMA"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/CCM.0b013e318236f7b8","article-title":"Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: A multicenter analysis*.","volume":"40","author":"Dreiher","year":"2012","journal-title":"Crit Care Med"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcrc.2004.10.005","article-title":"Epidemiology and economic evaluation of severe sepsis in France: Age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost.","volume":"20","author":"Adrie","year":"2005","journal-title":"J Crit Care"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jama.1995.03530120060042","article-title":"Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.","volume":"274","author":"Brun-Buisson","year":"1995","journal-title":"JAMA"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","article-title":"Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.","volume":"28","author":"Alberti","year":"2002","journal-title":"Intensive Care Med"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5492\/wjccm.v1.i1.23","article-title":"Severe sepsis and septic shock in the elderly: An overview.","volume":"1","author":"Nasa","year":"2012","journal-title":"World J Crit Care Med"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2012.09.016","article-title":"Ethnicity and sepsis characteristics and outcomes. Population based study.","volume":"24","author":"Karp","year":"2013","journal-title":"Eur J Intern Med"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1161\/STROKEAHA.117.018531","article-title":"Increase of stroke incidence in young adults in a middle-income country: A 10-year population-based study.","volume":"48","author":"Cabral","year":"2017","journal-title":"Stroke"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.amjcard.2017.07.081","article-title":"Comparison of readmission rates after acute myocardial infarction in 3 patient age groups (18 to 44, 45 to 64, and \u226565 years) in the United States.","volume":"120","author":"Khera","year":"2017","journal-title":"Am J Cardiol"},{"key":"R29-20230816","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: Results of the SOAP study.","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.CCM.0000260960.94300.DE","article-title":"Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward.","volume":"35","author":"Esteban","year":"2007","journal-title":"Crit Care Med"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/cc8138","article-title":"One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: A before and after study.","volume":"13","author":"Puskarich","year":"2009","journal-title":"Crit Care"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.","volume":"273","author":"Rangel-Frausto","year":"1995","journal-title":"JAMA"},{"key":"R33-20230816","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/sur.2008.012","article-title":"Has mortality from sepsis improved and what to expect from new treatment modalities: Review of current insights.","volume":"10","author":"van Ruler","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0000000000000503","article-title":"Long-term (10-year) mortality of younger previously healthy patients with severe sepsis\/septic shock is worse than that of patients with nonseptic critical illness and of the general population.","volume":"42","author":"Linder","year":"2014","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201808000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T21:01:05Z","timestamp":1692133265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201808000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003205","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}